These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37887688)

  • 21. Past-year prevalence of prescription opioid misuse among those 11 to 30years of age in the United States: A systematic review and meta-analysis.
    Jordan AE; Blackburn NA; Des Jarlais DC; Hagan H
    J Subst Abuse Treat; 2017 Jun; 77():31-37. PubMed ID: 28476268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
    Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid overdose among Medicaid patients.
    Hoffman KL; Milazzo F; Williams NT; Samples H; Olfson M; Diaz I; Doan L; Cerda M; Crystal S; Rudolph KE
    Psychol Med; 2024 May; 54(7):1419-1430. PubMed ID: 37974483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of overdose in the synthetic opioid era.
    Skolnick P
    Pharmacol Ther; 2022 May; 233():108019. PubMed ID: 34637841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone Knowledge and Attitudes of Juvenile Residents in a Detention Setting.
    Hammond A; Obrecht J; Odunuyi O; Magloire P; Walsh S
    J Correct Health Care; 2022 Jun; 28(3):148-154. PubMed ID: 35263179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
    Alexander GC; Ballreich J; Mansour O; Dowdy DW
    Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2).
    Elliott L; Crasta D; Khan M; Roth A; Green T; Kolodny A; Bennett AS
    Drug Alcohol Depend; 2021 Jun; 223():108721. PubMed ID: 33895681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advocating for a Thoughtful Expansion of Safer Supply to Realize Bold Impact on Opioid Overdose.
    Dunn KE
    J Stud Alcohol Drugs; 2022 Jul; 83(4):621-622. PubMed ID: 35838441
    [No Abstract]   [Full Text] [Related]  

  • 29. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
    Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
    Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment.
    Bryson WC; Morasco BJ; Cotton BP; Thielke SM
    Subst Use Misuse; 2021; 56(5):697-703. PubMed ID: 33749499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review of Simulation Models to Track and Address the Opioid Crisis.
    Cerdá M; Jalali MS; Hamilton AD; DiGennaro C; Hyder A; Santaella-Tenorio J; Kaur N; Wang C; Keyes KM
    Epidemiol Rev; 2022 Jan; 43(1):147-165. PubMed ID: 34791110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid Misuse: A Review of the Main Issues, Challenges, and Strategies.
    Biancuzzi H; Dal Mas F; Brescia V; Campostrini S; Cascella M; Cuomo A; Cobianchi L; Dorken-Gallastegi A; Gebran A; Kaafarani HM; Marinangeli F; Massaro M; Renne A; Scaioli G; Bednarova R; Vittori A; Miceli L
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for severe respiratory depression from prescription opioid overdose.
    Fox LM; Hoffman RS; Vlahov D; Manini AF
    Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staring down the opioid epidemic.
    Unger JR
    J Fam Pract; 2017 Jan; 66(1):8. PubMed ID: 28188310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities.
    Cheatle MD
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):751-4. PubMed ID: 26933873
    [No Abstract]   [Full Text] [Related]  

  • 38. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
    Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of an opioid pain teleconsultation service to address the opioid overdose epidemic in Colorado: A Health First Colorado demonstration project.
    Anderson HD; Patterson V; Wright G; Rawlings JE; Moore GD; Utter B; Taylor J; Leonard J; Page RL
    J Am Pharm Assoc (2003); 2023; 63(1):301-308. PubMed ID: 36528493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose.
    Karmali RN; Ray GT; Rubinstein AL; Sterling SA; Weisner CM; Campbell CI
    Drug Alcohol Depend; 2020 Apr; 209():107923. PubMed ID: 32126455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.